Gou Ji (Cibotium barometz): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Gou Ji work for lower back pain?

Gou Ji (Cibotium barometz) works through its active saponins and tannic acid compounds, which demonstrate anti-inflammatory properties that may reduce tissue inflammation in the lumbar region. In Traditional Chinese Medicine theory, it strengthens the Kidney meridian, which governs the lower back and knees. The herb's starch content provides nutritive support while fatty acids contribute to its restorative effects on connective tissue. Evidence level: C, based primarily on traditional use and preliminary pharmacological studies.

Does Gou Ji interact with any medications?

There are currently no well-documented drug interactions for Gou Ji in clinical literature. However, due to its astringent properties and effects on urinary function, it may theoretically interact with diuretics, anticholinergic medications, or drugs affecting bladder control. Patients taking prescription medications should consult a qualified healthcare provider before adding Gou Ji to their regimen. Evidence level: C, based on limited pharmacological data.

What is the recommended dosage for Gou Ji?

The standard adult dosage for Gou Ji is 9-15 grams of dried rhizome daily when prepared as a decoction, or 500mg of standardized extract taken twice daily. Dosage may vary based on the specific formulation, severity of symptoms, and individual constitution. Traditional Chinese Medicine practitioners often adjust doses based on pulse and tongue diagnosis. Always follow professional guidance for appropriate dosing tailored to your condition.

Is Gou Ji safe to take during pregnancy?

Gou Ji is considered unsafe during pregnancy and should be avoided. Its urinary-strengthening and astringent properties may affect fetal development, and Traditional Chinese Medicine explicitly contraindicates its use during pregnancy due to potential uterine effects. Additionally, the herb's warming nature may exacerbate conditions involving excess heat. Pregnant individuals experiencing lower back discomfort should consult their healthcare provider for pregnancy-safe alternatives.

What conditions does Gou Ji treat in Traditional Chinese Medicine?

Gou Ji is primarily used in Traditional Chinese Medicine to strengthen the Kidney and Liver systems, addressing weakness of the lumbar spine, chronic knee pain, urinary incontinence, and vaginal discharge. It is considered a key herb for conditions involving Kidney deficiency, which manifests as lower back weakness, knee instability, and urinary dysfunction. Evidence level: C, supported by traditional use records and emerging anti-inflammatory research.

What are the side effects of taking Gou Ji?

Gou Ji typically produces minimal side effects when taken at recommended doses. However, it is contraindicated in individuals with excess heat conditions, as it may worsen symptoms such as inflammation, fever, or irritability. Some individuals may experience mild digestive discomfort. Those with known fern allergies should exercise caution. Discontinue use and consult a qualified practitioner if adverse reactions occur.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Cibotium barometz, known as Gou Ji, is a medicinal tree fern used in traditional medicine to treat musculoskeletal, age-related, and joint conditions [PMID:37416896, 41424557].

Background

Cibotium barometz (Linn.) J. Sm. is a tree fern in the Dicksoniaceae family and is an economically important industrial exported plant in China [PMID:37416896]. It is an endangered CITES medicinal fern [PMID:33490515].

Traditional uses

It is widely used in Traditional Chinese Medicine as a tonifying kidney drug for osteoarthritis [PMID:35873632] and to treat pain, weakness, and numbness in the lower extremities [PMID:37346120]. It has a history of use in China, India, and Vietnam for bone pain, urinary system diseases, and reproductive disorders [PMID:40848860]. In Malaysia, it has been used for the treatment of gastric ulcers [PMID:28408799].

Active compounds

The plant produces bioactive triterpenes [PMID:37416896], phenylpropanoids, polyphenols, flavonoids, terpenoids, steroids, and polysaccharides [PMID:40848860]. Specific identified compounds include protocatechuic acid, (+)-catechin hydrate, p-coumaric acid, and ellagic acid [PMID:37834245], as well as hemiterpene glycosides (cibotiumbarosides E-I) [PMID:28262248] and unusual sesquiterpenes with a 1-indanone nucleus [PMID:19635547].

Mechanism of action

Cibotium barometz polysaccharides may promote bone formation by activating the BMP2/SMAD1 signaling pathway [PMID:31888819] and stimulate chondrocyte proliferation by promoting G1/S cell cycle transition [PMID:2835841 la]. In the context of osteoarthritis, it may inhibit the activation of MAPK/NF-κB signaling pathways [PMID:40360133]. It has also been shown to inhibit osteoclast formation without affecting BMM cell viability [PMID:19739599].

Clinical evidence

Evidence BDental Caries

A mouthwash containing C. barometz significantly decreased caries-related indicators, including the O'Leary plaque index and caries activity, compared to saline and chlorhexidine [PMID:39041359]

Evidence DOsteoporosis

Cibotium barometz extract prevented the decrease of total bone mineral density (BMD) in the femur of ovariectomized rats [PMID:21782010]

Evidence DMuscle Atrophy

Ethanol extract of C. barometz showed a protective effect against dexamethasone-induced muscle atrophy in C2C12 myotubes in vitro [PMID:37834245]

Evidence DHepatotoxicity

Cibotiumbarosides F and I exhibited hepatoprotective activity against APAP-induced acute liver damage in vitro [PMID:28262248]

Evidence DSARS-CoV Replication

Extracts of C. barometz were found to be potent inhibitors of SARS-CoV in a cell-based assay [PMID:24716104]

Evidence summary

The evidence consists primarily of in vitro cell studies and animal models (Level D), with one randomized blinded clinical trial (Level B) regarding dental health. Most musculoskeletal claims are based on preclinical data.

PubMed sources

1.PMID: 37416896 (2023) — Functional characterization of triterpene synthases in Cibotium barometz. · Synthetic and systems biotechnology
2.PMID: 37834245 (2023) — Protective Role of Ethanol Extract of Cibotium barometz (Cibotium Rhizome) against Dexamethasone-Induced Muscle Atrophy in C2C12 Myotubes. · International journal of molecular sciences
3.PMID: 40585988 (2025) — Tailorable bimetallic nanozyme mitigates intervertebral disc degeneration by inhibiting oxidative stress and inflammageing. · Theranostics
4.PMID: 33490515 (2018) — The complete chloroplast genome of Cibotium barometz (Cibotiaceae), an endangered CITES medicinal fern. · Mitochondrial DNA. Part B, Resources
5.PMID: 35873632 (2022) — Network Pharmacology-Based Strategy to Investigate the Mechanisms of Cibotium barometz in Treating Osteoarthritis.

Gou Ji

Sources & Citations

Calculate a safe dose of Gou Ji